VectivBio Holding AGNASDAQ VECT Stock Report

VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the development of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 32 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.